Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-056307
Filing Date
2022-11-09
Accepted
2022-11-09 20:30:42
Documents
2
Period of Report
2022-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1608
2 POA DOCUMENT poa.txt EX-24 3624
  Complete submission text file 0001209191-22-056307.txt   6574
Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Shacham Sharon (Reporting) CIK: 0001588438 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41551 | Film No.: 221374547

Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

EIN.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations